STUDY OF 2 CONTROLLED-RELEASE THEOPHYLLINE PREPARATIONS

被引：8

作者：

FINK, JN ^{[1
]}

LEVY, MB ^{[1
]}

CONRAD, E ^{[1
]}

机构：

[1] PURDUE FREDERICK CO,NORWALK,CT

来源：

关键词：

D O I：

10.1016/0002-9343(85)90090-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：58 / 61

页数：4

共 14 条

[1] BELL T, 1978, PEDIATRICS, V62, P352
[2] SERUM PROFILE AND BIOAVAILABILITY OF A CONTROLLED-RELEASE THEOPHYLLINE FORMULATION FOR ONCE-DAILY USE - COMPARISON WITH A 12-HR PREPARATION
COHEN, BM
[J]. JOURNAL OF ASTHMA, 1984, 21 (05) : 305 - 309
[3] COMPARISON OF STANDARD-RELEASE AND SUSTAINED-RELEASE THEOPHYLLINE TABLETS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
DASTA, J
MIRTALLO, JM
ALTMAN, M
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (05): : 613 - 617
[4] HENDELES L, 1978, AM J DIS CHILD, V132, P876
[5] A CLINICAL AND PHARMACOKINETIC BASIS FOR THE SELECTION AND USE OF SLOW RELEASE THEOPHYLLINE PRODUCTS
HENDELES, L
IAFRATE, RP
WEINBERGER, M
[J]. CLINICAL PHARMACOKINETICS, 1984, 9 (02) : 95 - 135
[6] ABSOLUTE BIOAVAILABILITY OF ORAL THEOPHYLLINE
HENDELES, L
WEINBERGER, M
BIGHLEY, L
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (05): : 525 - 527
[7] HORODNIAK J, COMMUNICATION
[8] CLINICAL EXPERIENCE WITH THEOPHYLLINE - RELATIONSHIPS BETWEEN DOSAGE, SERUM CONCENTRATION, AND TOXICITY
JACOBS, MH
SENIOR, RM
KESSLER, G
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (18): : 1983 - 1986
[9] MITENKO PA, 1974, CLIN PHARMACOL THER, V16, P720
[10] RALL TW, 1980, PHARMACOL BASIS THER, P602